Breaking news

Explosive Growth In MENA’s Startup Ecosystem

February marked a groundbreaking month for MENA’s startup landscape, with an impressive $494 million raised across 58 deals—almost five times more than last year’s total for the same month. While Saudi Arabia dominated with $250.3 million accrued over 25 deals, the UAE and Egypt followed suit with $203.5 million and $27.5 million respectively.

Debt Financing Dips In February

Unlike January, where debt financing took the bulk of investments, February saw it drop to just 15% of total funding. The exclusion of debt reveals a staggering 371% increase in investment activity, highlighting a promising shift in financial dynamics.

Industry Leaders And Rising Sectors

Fintech emerged as the leading sector, delivering $274 million over 15 deals. Insurtech and logistics took the next spots, with $55 million and $28.5 million respectively. This upswing showcases both sustained interest and escalating financial backing for key tech industries.

Regional Contributions and Gender Disparities

B2B models attracted the most attention in February, garnering $191.6 million through 33 transactions. However, gender disparities remain, as startups led by male founders bagged 87% of the total investment. Despite the progress, this underlines the need for more equitable funding allocations.

For further insights into startup ecosystems, explore how Cyprus is setting new records in global startup growth.

Anthropic Acquires Coefficient Bio In $400 Million Stock Deal

Anthropic acquired biotech AI startup Coefficient Bio in a deal valued at approximately $400 million in stock, according to people familiar with the matter. Sources confirmed the transaction, although detailed financial terms were not publicly disclosed.

Deepening Forays Into Healthcare And Life Sciences

The acquisition follows Anthropic’s earlier launch of Claude for Life Sciences, a tool designed to support scientific research and drug discovery. The deal expands the company’s activity in healthcare and biotechnology. Anthropic is increasing its focus on applying AI models to scientific workflows, including data analysis and experimental design. Expansion into life sciences reflects broader industry trends.

Transforming Computational Drug Discovery

Coefficient Bio was founded eight months ago by Samuel Stanton and Nathan C. Frey, both former researchers at Genentech’s Prescient Design group. The company focused on applying AI to drug discovery and biological research processes. Its technology aims to improve efficiency in identifying drug candidates and analyzing biological data. Early-stage development reflects growing interest in AI-driven research tools.

Strategic Talent And Expertise Integration

Around 10 employees from Coefficient Bio will join Anthropic following the acquisition, strengthening its health and life sciences team. The group will contribute to the development of AI models for scientific and medical applications. Access to specialized talent supports the expansion of capabilities in drug discovery and biological research.

Industry Context And Outlook

Investment in AI for drug discovery has increased as companies seek to reduce development timelines and costs. Large technology firms and startups are expanding activity in this area. Further developments will depend on how effectively Anthropic integrates the team and advances its life sciences strategy.

eCredo
The Future Forbes Realty Global Properties
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter